{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:43:11Z","timestamp":1792683791700,"version":"4.5.0"},"reference-count":45,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Inonu University Scientific Research Projects Coordination Unit","award":["TSA-2026-4616"],"award-info":[{"award-number":["TSA-2026-4616"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Sarcopenia and impaired bone quality are increasingly recognized as important determinants of outcomes after liver transplantation (LT). However, longitudinal data describing early post-transplant musculoskeletal changes in patients with chronic hepatitis B virus (HBV) infection, particularly according to hepatocellular carcinoma (HCC) status, remain limited. Aim: To evaluate longitudinal changes in skeletal muscle mass and vertebral bone attenuation after LT in patients with chronic HBV infection and to assess the impact of concomitant HCC and clinical subgroups on these patterns. Methods: This retrospective, single-center study included 99 adult patients who underwent LT for chronic HBV infection (HBV alone, n = 59; HBV + HCC, n = 40) between January 2018 and December 2024. Contrast-enhanced abdominal computed tomography examinations obtained before transplantation and at approximately 6 (POD180) and 12 months (POD365) after transplantation were analyzed. Skeletal muscle was assessed using psoas muscle area (PMA) and psoas muscle index (PMI), while bone quality was evaluated using mean vertebral trabecular attenuation averaged across L1\u20134. Longitudinal changes were examined according to HCC status, sex, Child\u2013Pugh class, and survival status. Results: Repeated-measures analyses of longitudinal changes demonstrated a significant decline in both PMA and PMI at POD180 and POD365 compared with pre-transplant values (PMA: p = 0.006; PMI: p = 0.009). These patterns were comparable between patients with HBV alone and those with HBV-related HCC, with no significant differences between groups (all p &gt; 0.05). Male patients consistently exhibited higher PMA and PMI values than female patients across all assessed time points (both p &lt; 0.001). In contrast, neither Child\u2013Pugh class nor mortality status was associated with differences in PMA or PMI levels (all p &gt; 0.05). L1\u20134 attenuation declined markedly by POD180 and remained below baseline at POD365 (p &lt; 0.001). Although overall L1\u20134 values did not differ between disease groups (p = 0.109), the temporal pattern of L1\u20134 change differed according to survival status (p = 0.026), with a greater decline observed in non-survivors. Conclusions: In patients with chronic HBV undergoing LT, early post-transplant loss of skeletal muscle and vertebral bone attenuation is common and persists throughout the first year of follow-up. These changes occur similarly in patients with and without HCC. CT-based assessment of muscle and bone parameters, particularly L1\u20134 attenuation, may therefore support early post-transplant risk stratification.<\/jats:p>","DOI":"10.3390\/diagnostics16091340","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:34:42Z","timestamp":1777458882000},"page":"1340","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Longitudinal CT-Based Assessment of Muscle and Bone Changes After Liver Transplantation in Hepatitis B Patients with and Without Hepatocellular Carcinoma"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9342-0244","authenticated-orcid":false,"given":"Nurullah","family":"Dag","sequence":"first","affiliation":[{"name":"Department of Radiology, Inonu University Faculty of Medicine, 44280 Malatya, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6864-7711","authenticated-orcid":false,"given":"Sami","family":"Akbulut","sequence":"additional","affiliation":[{"name":"Department of Surgery and Liver Transplantation, Inonu University Faculty of Medicine, 44280 Malatya, T\u00fcrkiye"},{"name":"Department of Biostatistics and Medical Informatics, Inonu University Faculty of Medicine, 44280 Malatya, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"Sahin","sequence":"additional","affiliation":[{"name":"Department of Radiology, Inonu University Faculty of Medicine, 44280 Malatya, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0899-9007(99)00121-5","article-title":"Bone loss at the proximal femur and reduced lean mass following liver transplantation: A longitudinal study","volume":"15","author":"Keogh","year":"1999","journal-title":"Nutrition"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-024-02072-z","article-title":"Liver diseases: Epidemiology, causes, trends and predictions","volume":"10","author":"Gan","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jceh.2019.12.003","article-title":"Sarcopenia in Cirrhosis: Fallout on Liver Transplantation","volume":"10","author":"Kumar","year":"2020","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Lee, C.-M., Kang, B.K., and Kim, M. (2021). Radiologic definition of sarcopenia in chronic liver disease. Life, 11.","DOI":"10.3390\/life11020086"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"G241","DOI":"10.1152\/ajpgi.00373.2020","article-title":"Sarcopenia in chronic liver disease: Mechanisms and countermeasures","volume":"320","author":"Allen","year":"2021","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jcsm.12269","article-title":"Association between pre-sarcopenia, sarcopenia, and bone mineral density in patients with chronic hepatitis C","volume":"9","author":"Bering","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/lt.24458","article-title":"Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients","volume":"22","author":"Sharma","year":"2016","journal-title":"Liver Transpl."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Li, Z., Cao, J., Li, K., Wu, Y., Luo, Z., Cao, R., Cheng, Z., Tian, Z., Han, Y., and Lai, Y. (2025). Causal associations between osteoporosis and HBV infection across Asian and European populations: Evidence from Mendelian randomization and colocalization analysis. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1419303"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kamiliou, A., Lekakis, V., Xynos, G., and Cholongitas, E. (2024). Prevalence of and Impact on the Outcome of Myosteatosis in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Cancers, 16.","DOI":"10.3390\/cancers16050952"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s10238-025-01671-6","article-title":"Myosteatosis and the survival of patients with hepatocellular carcinoma: A meta-analysis","volume":"25","author":"Wu","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Takada, H., Osawa, L., Komiyama, Y., Muraoka, M., Suzuki, Y., Sato, M., Kobayashi, S., Yoshida, T., Takano, S., and Maekawa, S. (2025). Serum interferon-gamma-induced protein 10 levels can help predict sarcopenia development in patients with primary hepatocellular carcinoma: A retrospective cohort study. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0309852"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Peng, T.-R., Wu, C.-C., Hsiao, J.-K., Chou, Y.-C., Liao, Y.-L., Chen, Y.-C., Shao, P.-J., Wu, T.-W., and Hsu, C.-S. (2024). Integrating Muscle Depletion with Barcelona Clinic Liver Cancer Staging to Predict Overall Survival in Hepatocellular Carcinoma. Cancers, 17.","DOI":"10.3390\/cancers17010024"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00595-025-03008-y","article-title":"Effect of sarcopenia on the survival of patients undergoing liver transplantation: A meta-analysis","volume":"55","author":"Akabane","year":"2025","journal-title":"Surg. Today"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e14416","DOI":"10.1111\/ctr.14416","article-title":"Investigation of the prognostic value of psoas muscle area measurement in pediatric patients before liver transplantation: A single-center retrospective study","volume":"35","author":"Dag","year":"2021","journal-title":"Clin. Transplant."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e20241672","DOI":"10.1590\/1806-9282.20241672","article-title":"Opportunistic computed tomography-based sarcopenia screening and mortality after liver transplantation: A systematic review and meta-analysis","volume":"71","author":"Fernandes","year":"2025","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e70410","DOI":"10.1111\/ctr.70410","article-title":"Decrease in Psoas Muscle Mass and Density Following Liver Transplantation Is Greatest in Patients with the Highest Muscle Quantity and Density Pre-Transplant","volume":"39","author":"Megaly","year":"2025","journal-title":"Clin. Transplant."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"962","DOI":"10.21037\/hbsn-23-645","article-title":"The rate of muscle wasting in liver transplant recipients on waiting list: Post-transplant outcomes and associated serum metabolite patterns","volume":"13","author":"Rokop","year":"2024","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/jlts.2003.50044","article-title":"Osteoporosis after liver transplantation","volume":"9","author":"Compston","year":"2003","journal-title":"Liver Transpl."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.5152\/EurJTher.2022.21081","article-title":"Scoliosis After Liver Transplantation in Pediatric Patients","volume":"28","author":"Dag","year":"2022","journal-title":"Eur. J. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Dag, N., Ulubaba, H.E., Tasolar, S., Candur, M., and Akbulut, S. (2025). Opportunistic Bone Health Assessment Using Contrast-Enhanced Abdominal CT: A DXA-Referenced Analysis in Liver Transplant Recipients. Diagnostics, 16.","DOI":"10.3390\/diagnostics16010029"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1148\/radiol.2019181648","article-title":"Opportunistic osteoporosis screening at routine abdominal and thoracic CT: Normative L1 trabecular attenuation values in more than 20,000 adults","volume":"291","author":"Jang","year":"2019","journal-title":"Radiology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7326\/0003-4819-158-8-201304160-00003","article-title":"Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications","volume":"158","author":"Pickhardt","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/iju.iju_385_25","article-title":"The role of psoas muscle index in predicting outcomes after radical cystectomy","volume":"42","author":"Duarte","year":"2026","journal-title":"Indian J. Urol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Bolte, F.J., McTavish, S., Wakefield, N., Shantzer, L., Hubbard, C., Krishnaraj, A., Novicoff, W., Gentzler, R.D., and Hall, R.D. (2022). Association of sarcopenia with survival in advanced NSCLC patients receiving concurrent immunotherapy and chemotherapy. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.986236"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.surg.2017.03.014","article-title":"Computed tomography measured psoas density predicts outcomes in trauma","volume":"162","author":"Yoo","year":"2017","journal-title":"Surgery"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Tuncer, A., Akbulut, S., Sahin, T.T., Satilmis, B., Ogut, Z., Dalda, Y., and Yilmaz, S. (2025). Prospective Analysis of Perioperative Stress Response in Living Donor Liver Transplantation for Hepatitis B-Related Liver Disease. J. Clin. Med., 14.","DOI":"10.3390\/jcm14248970"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration","volume":"12","author":"Vandenbroucke","year":"2014","journal-title":"Int. J. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.4314\/ahs.v20i4.13","article-title":"Association between osteoporosis and hepatitis B cirrhosis: A case-control study","volume":"20","author":"Zhang","year":"2020","journal-title":"Afr. Health Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12072-021-10148-z","article-title":"A novel evidence of serial changes of bone mineral density in chronic hepatitis B patients treated with entecavir","volume":"15","author":"Huang","year":"2021","journal-title":"Hepatol. Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00198-025-07602-1","article-title":"Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis","volume":"36","author":"Ko","year":"2025","journal-title":"Osteoporos. Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/jcsm.13053","article-title":"Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria","volume":"13","author":"Beumer","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1007\/s12072-024-10708-z","article-title":"Impact of CT-relevant skeletal muscle parameters on post-liver transplantation survival in patients with hepatocellular carcinoma","volume":"18","author":"Li","year":"2024","journal-title":"Hepatol. Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/jcsm.13554","article-title":"Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma","volume":"15","author":"Lu","year":"2024","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_34","first-page":"4","article-title":"The impact of sarcopenia on the outcome of patients with cirrhosis with and without hepatocellular carcinoma who undergo liver transplantation","volume":"7","author":"Zanetto","year":"2021","journal-title":"Hepatoma Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.acra.2023.03.001","article-title":"Radiological Quantification of Sarcopenic Obesity and its Role in Chronic Liver Disease Severity","volume":"30","author":"Cimsit","year":"2023","journal-title":"Acad. Radiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"18316","DOI":"10.1038\/s41598-022-21652-z","article-title":"Osteopenia is associated with inferior survival in patients undergoing partial hepatectomy for hepatocellular carcinoma","volume":"12","author":"Meister","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_37","first-page":"e80490","article-title":"The Incidence of Osteoporosis in Hepatocellular Carcinoma Patients Under 65: A Retrospective Cohort Study","volume":"17","author":"Tibbetts","year":"2025","journal-title":"Cureus"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00268-019-05206-5","article-title":"Prognostic impact of osteopenia in patients who underwent living donor liver transplantation for hepatocellular carcinoma","volume":"44","author":"Toshima","year":"2020","journal-title":"World J. Surg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0038-1676806","article-title":"Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets","volume":"39","author":"Yang","year":"2019","journal-title":"Semin. Liver Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1007\/s00464-025-12011-w","article-title":"Long-term outcomes in deceased versus living donor liver transplantation for hepatocellular carcinoma: A bi-institutional study of 486 cases","volume":"39","author":"Guidetti","year":"2025","journal-title":"Surg. Endosc."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Yang, Y., He, Y.C., Cai, Y.S., Lv, Y.H., Liu, C., and Wu, H. (2025). Living Donor Liver Transplantation Versus Deceased Donor Liver Transplantation for Hepatocellular Carcinoma and HCV Patients: An Initial Umbrella Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14093047"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s12029-020-00482-0","article-title":"Do We Need to Be Limited by Matching Milan Criteria for Survival in Living Donor Liver Transplantation?","volume":"51","author":"Akbulut","year":"2020","journal-title":"J. Gastrointest. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kokudo, T., and Kokudo, N. (2025). Evolving Indications for Liver Transplantation for Hepatocellular Carcinoma Following the Milan Criteria. Cancers, 17.","DOI":"10.3390\/cancers17030507"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1038\/ctg.2015.31","article-title":"Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis","volume":"6","author":"Baracos","year":"2015","journal-title":"Clin. Transl. Gastroenterol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/9\/1340\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:55:52Z","timestamp":1777460152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/9\/1340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":45,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["diagnostics16091340"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16091340","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]}}}